Gamma-ray spectroscopy with incomplete fusion reactions for the systems 16O +58,64Ni at 100 Me V |
| |
| Institution: | 1. Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, MI, USA;2. Population Health Program, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia;3. Centre for Cancer Research, The Westmead Institute for Medical Research, Sydney, NSW, Australia;4. Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia;5. Department of Gynaecological Oncology, Westmead Hospital, Sydney, NSW, Australia;6. The Daffodil Centre, The University of Sydney, a joint venture with Cancer Council NSW, Sydney, NSW, Australia;7. Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia;8. Sir Peter MacCallum Department of Oncology, The University of Melbourne, Victoria, Australia;9. Department of Public Health, California State University, Fullerton, Fullerton, CA, USA;10. Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia;11. David Geffen School of Medicine, Department of Medicine Division of Hematology and Oncology, University of California at Los Angeles, Los Angeles, California, USA;12. Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-EMN, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg (FAU), Erlangen, Germany;13. Department of Quantitative Health Sciences, Division of Epidemiology, Mayo Clinic, Rochester, MN, USA;14. Samuel Oschin Comprehensive Cancer Institute, Cancer Prevention and Genetics Program, Cedars-Sinai Medical Center, Los Angeles, CA, USA;15. Community and Population Health Research Institute, Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA;p. David Geffen School of Medicine, Department of Obstetrics and Gynecology, University of California at Los Angeles, Los Angeles, CA, USA;q. Division of Cancer Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Japan;r. Women''s Cancer Research Center, Magee-Women''s Research Institute and Hillman Cancer Center, Pittsburgh, PA, USA;s. Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA;t. Department of Epidemiology, University of Pittsburgh Graduate School of Public Health, Pittsburg, PA, USA;u. Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK;v. Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University Hospital Leuven, Leuven Cancer Institute, Leuven, Belgium;w. Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK;x. Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK;y. Emory University Rollins School of Public Health, Atlanta, GA, USA;z. Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Michigan Medical School, Ann Arbor, MI, USA;11. Department of Biostatistics, University of Michigan School of Public Health, Ann Arbor, MI, USA;12. Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA;13. Patient Advocate;14. Department of Epidemiology, Harvard TH Chan School of Public Health, Boston, MA, USA;15. Obstetrics and Gynecology Epidemiology Center, Brigham and Women''s Hospital and Harvard Medical School, Boston, MA, USA;16. University of British Columbia Faculty of Medicine, Department of Obstetrics & Gynecology, Vancouver, Canada;17. Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA;18. Division of Gynecologic Oncology, Duke University School of Medicine, Durham, NC, USA;19. School of Clinical Medicine, Faculty of Medicine and Health, University of NSW, Sydney, New South Wales, Australia;110. Adult Cancer Program, Lowy Cancer Research Centre, University of NSW, Sydney, New South Wales, Australia;111. Department of Integrative Oncology, BC Cancer Research Institute, Vancouver, Canada |
| |
| Abstract: | Energy spectra and angular distributions of ejectiles with 3 ⩽ Z ⩽ 7 have been measured for the reaction 16O on 64Ni at 100MeV incident energy. Measured optimum Q-values and cross sections are accounted for by an incomplete fusion model. Coincidences between ejectiles detected at grazing angle and discrete γ-rays have been measured for the reactions 100 MeV 16O+58,64Ni. The in-plane to out-of-plane anisotropies of discrete γ-rays show a high degree of spin polarization of incomplete fusion residues which can be exploited for spectroscopic studies. |
| |
| Keywords: | |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
